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Immunophenotyping is currently an integral part of 
modalities in diagnosis of acute leukemia along with 
morphology, cytochemistry and cytogenetics. However 
in financially constrained regions like Pakistan, 
judicious usage in a cost-effective manner is of 
paramount importance.
Primary goals for immunophenotyping in acute 
leukemia are lineage assignment of blasts and further 
sub-classification. Secondary goals include 
prognostication and minimal residual disease 
assessment.
We recommend performing immunophenotyping after 
met iculous  morphological  assessment  and 
histochemistry. This would help in the selection of 
panels in a cost -- effective fashion.
The following approaches are used in various 
laboratories:
• Upfront (single) comprehensive panel (Fig. 1, 2 
and 3)
• Primary screening panel followed by secondary 
directed panel
The second approach is more suitable in our scenario as 
it reduces the cost without compromising diagnosis. 
Here, primary panel composed of most sensitive  
markers for each lineage is able to diagnose most 
leukemias without additional testing. This should be as 
minimal a panel as necessary.
Following panels are recommended by  Histopathology 
Section of AKUH,: 
B-cell: CD19 and CD10
T-cell: CD7 and CD3 (cyto)
Myeloid: CD13 and CD33
B- Cell: CD20, CD22, cCD79a, IgG, IgM, Kappa, 
lambda, HLA-DR and Tdt
Primary Panel
Secondary Panel
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Acute Leukemia Immunophenotyping with 
Pakistani Perspective
Dr Shahid Pervez, Histopathology
Figure 1: A comprehensive panel in a child with acute leukemia. 
Note blast gating on CD45 dim population. This population is 
showing prominent reactivity with B cell markers cCD79a, CD19, 
CD20, CD10, CD22 & cTdt along with HLA-DR consistent with 
'Commen Pre-B-All'.
Figure 2: A comprehensive panel in a young, adult with acute 
leukemia. Note blast gating on a CD45 dim population. This 
population is showing prominent reactivity with T-Cell markers 
CD3, CD5 and CD7 along with cTdt consistent with 'Pre-T-ALL'.
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PAX5: Immunohistochemistry Marker for B cell 
Lymphoproliferative Disorders
Muhammad Rahil Khan; Arsalan Ahmed, Histopathology
PAX5 (B-cell-specific activator protein, BSAP) is a 
member of the paired-box domain gene family that 
encodes nuclear transcription 
fac tors .  The  la t te r  a re  
important in development, 
differentiation, cell migration 
and prol i fera t ion of  B 
lymphocytes. PAX5 protein is 
expressed as a nuclear marker 
in B-lineage cells that span the 
differentiation spectrum in 
pro-, pre-, and mature B cells, 
but are not expressed in 
plasma cells at all. Hence, 
PAX5 protein is also a useful 
lineage-specific marker in 
hematopoietic neoplasms 
arising from B cells.
Staining for PAX5 has utility 
in the diagnosis of B cell malignancies that lack 
expression of commonly used pan-B-cell markers such 
as CD20 and CD79a, especially acute lymphoblastic 
leukemia, lymphoma and post-Rituxamab treatment.  In 
addition to its expression in B cells, PAX5 protein 
and/or mRNA have been 
reported to be expressed in 
neoplasms of central nervous 
system, testis and bladder. 
PAX5 is the most sensitive and 
reliable immunohistochemical 
marker for B cell malignancies 
since PAX5 will always be 
expressed in the absence of 
expression of other pan- B -
cell markers, suggesting that 
the inclusion of PAX5 in a 
panel of antibodies to diagnose 
B cell lymphomas would be 
v e r y  h e l p f u l .  A K U H  
Laboratory has recently added 
t h i s  m a r k e r  i n  t h e  
immunohistochemistry profile for tumors and 
lymphoproliferative disorders
Figure 1:Bone trephine biopsy showing diffuse positivity to PAX5
T-Cell: CD5, CD4, CD8, CD56, HLA-DR and Tdt
Myeloid: MPO, CD14, HLA-DR, CD117, CD61
All samples must be tested for viability and gating 
(selecting) of the blast population by Leucogate. This is 
using CD45 (LCA) with side scatter (SS) and as blast 
population is invariably dim for CD45, it can be selected 
for further analysis.
Samples of bone marrow or blood should be obtained  
fresh possibly not over 48 hours in heparanised or EDTA 
tubes (3-4 cc). Transportation from different cities and 
distant or remote areas should be according to the 
defined guidelines. It is necessary that a viability check 
be performed on arrival of sample before proceeding 
further. 
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Figure 3: A comprehensive panel in a middle-aged patient with
acute leukemia. Note blast gating on CD45 dim population. This
population is showing prominent reactivity with myeloid markers
cMPO, CD13 CD33 & CD14 alongwith HLA-DR consistent with
'Acute myelomonocytic leukemia (M4)'.
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Water Deprivation Test is performed to distinguish 
among the two major forms of Diabetes Insipidus (DI): 
Central and Nephrogenic. 
DI results from the deficiency or functional resistance of  
a pituitary hormone known as Antidiuretic hormone 
(ADH) or vasopressin. ADH helps in conserving water 
by the kidneys . Consequent to low 
or subnormal ADH, the kidneys 
are unable to retain water during 
filtering blood resulting in 
polyuria. Hence, urine output may 
exceed three litres in a day in 
2adults and two litres/m  in children. 
Central DI results from trauma or 
tumor in pituitary gland with 
subsequent failure of the posterior 
 pituitaryto secrete ADH. Rarely, it 
can be familial due to mutation in 
ADH gene. This is an autosomal 
dominant disorder leading to 
misfolded ADH precursors which 
are not stable and are destroyed 
easily.
In contrast to central type, ADH 
secretion is normal in nephrogenic 
DI but is associated with varying 
degrees of renal resistance to its 
water retaining effect. Causes of 
Nephrogenic DI can be structural 
kidney defects due to hypercalcaemia, hypokalaemia 
and chronic lithium usage or mutations in auaporin-2 
gene or AVPR2 gene. [There are two different receptors 
for ADH: the V1 (AVPR1) and V2 (AVPR2) receptors. 
The AVPR2 gene is located on the X-chromosome (Xq-
28).]
Differential diagnosis of DI includes other causes of 
polyuria such as diabetes mellitus and, chronic renal 
failure (caused by osmotic diuretics, glucose and urea). 
Psychogenic polydipsia is an important cause of 
polyuria, which usually occurs in anxious middle-aged 
women, psychiatric illnesses, individuals taking 
phenothiazines causing dry mouth.
An unusual form of transient ADH-resistance disorder 
is gestational DI that is observed  in selected women 
during the second half of pregnancy. Pregnancy is 
associated with release of a vasopressinase from the 
placenta. This leads to rapid degradation of endogenous 
or exogenous ADH, but not of desmopressin. These 
women also present with polyuria.
The cause of polyuria is often suggested from the history, 
for example age of onset and eliciting the possible 
presence of the different causes of DI, and rarely by the 
plasma sodium concentration. Polyuria due to lack of 
ADH usually exceeds 5 litres daily. In DI there is a 
tendency for the serum osmolality to be increased above 
normal; the reverse is true in compulsive water drinkers.  
Specific testing is then performed to establish the 
diagnosis.
Water Deprivation Test helps in the diagnosis of DI. It is 
performed under constant medical supervision as it can 
potentially cause dehydration, fluid and salt imbalance. 
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Understanding the Water Deprivation Test
Dr Lena Jafri, Chemical Pathology
Figure 1: Relation between ADH and plasma Osmolality
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Water is restricted from 9:00 pm 
the night before the test until 
conclusion of the test. At 7:00 
am the next morning the bladder 
is emptied and this urine is 
discarded. The patient is 
weighed and is told to pass urine 
hourly beginning at 8:00 am.  
Urine osmolality is estimated 
and the test is continued until 
urine osmolality reaches 750 
mmol/L or it reaches a plateau. 
(Plateau is the difference 
b e t w e e n  c o n s e c u t i v e  
estimations of urine osmolality 
of less than 30 mmol/kg). When 
plateau is reached blood sample 
is drawn for serum osmolality.
Now ADH (Desmopressin 10 
microgram nasal insufflations 
or 4 microgram subcutaneously 
o r  5  u n i t s  o f  a q u e o u s  
vasopressin subcutaneously) is 
given. One hour later urine is 
collected for urine osmolality 
estimation.
Aga Khan Hospital Clinical 
Laboratory should be notified the day before testing to 
arrange for stat determinations of urine and serum 
osmolality and for immediate processing of plasma 
vasopressin.
The test is discontinued if urine osmolality is stable on 
two or three successive measurements despite a rising 
plasma osmolality or if the plasma osmolality exceeds 
295 to 300 mosmol/kg. The test is also halted if the 
patient loses >5% of their body weight.
Accurate interpretation of the water restriction test 
generally requires that exogenous ADH not be given 
before the urine osmolality has been stabilized or the 
plasma osmolality has reached 295 mosmol/kg. Below 
this level, maximum endogenous ADH effect may not 
be present and an antidiuretic response to ADH is of no 
diagnostic benefit, since it will raise the urine osmolality 
even in normal subjects (Figure 1). Central DI is usually 
partial. In the case of Central DI both ADH release and 
urine osmolality may increase as the plasma osmolality 
rises, but sub-maximally. Exogenous ADH will lead to a 
rise in urine osmolality of more than 100% in complete 
Central DI and 15 to 50% in partial Central DI (Figure 2). 
Nephrogenic DI is also associated with sub-maximal 
rise in urine osmolality in response to water restriction. 
Elevation in plasma osmolality stimulates ADH release. 
Most patients with acquired Nephrogenic DI are 
resistant to ADH hence no response is seen. If the history 
and water restriction test provide equivocal results 
plasma samples  collected at baseline and following 
water deprivation (prior to ADH administration) are 
sent for measurement of ADH. 
Note: This test can be done only under medical 
supervision as it can potentially cause dehydration, 
fluid and salt imbalance.
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Figure 2: Interpretation of Water Deprivation Test
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The hypothalamic gonadotropin releasing hormone 
(GnRH) stimulates release of both luteinizing hormone 
(LH) and follicle stimulating hormone (FSH) in normal 
individuals. Subnormal responses are seen in some 
patients with pituitary and hypothalamic disorders. 
However, the magnitude of FSH and LH response to 
GnRH is usually predictable from the basal FSH and LH 
levels.
GnRH stimulation test is useful in patients in whom the 
clinical picture and basal gonadotropins measurements 
are inconclusive. It is indicated in patients with 
precocious puberty (suspect pathologic central cause) 
and delayed puberty (suspect hormonal cause) 
The test may be performed without regard for previous 
feeding or time of day. After patient's consent, baseline 
specimens are obtained for LH and FSH determination. 
After that 100 µg of synthetic GnRH is given 
intramuscularly or intravenously, followed by sampling 
for serum levels of FSH and LH at 30, 45, 60 minutes 
(can be taken up to 180 minutes).
Peak responses to both FSH and LH occur between 30 
and 45 minutes. Patients with pituitary disorders may 
have normal, diminished or absent response. Normally 
LH response should increase by 3-10 fold. The FSH 
response is of lesser magnitude, usually 1.5-3 fold 
increase in patients with hypothalamic disorders; the 
response may be exaggerated, normal, diminished or 
absent. In the case of Gonadotropins-independent 
precocious puberty, no increase over basal levels is 
observed. FSH and LH response is termed flat.
Instruction about use of medicine, dose and timings 
of samples can be followed as per physician request.
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Gonadotropins Releasing Hormone (GnRH)
Stimulation Test
Dr Noreen Sherazi, Chemical Pathology
A seven-year old child presented to haematology clinic 
with complaints of fever and failure to thrive since two 
months. Past history was significant for repeated upper 
respiratory infections. Examination revealed pallor. 
There was no hepatosplenomegaly. A complete blood 
count showed hemoglobin of 6.2 gm/dl, haematocrit 
19%, normal red cell indices. WBC of 3.7 x10E9/L, 
ANC 1.6 x 10E9/L and Platelets 122 x 10E9/L. 
Peripheral blood picture is attached. Please comment on 
the peripheral film and give your most probable 
diagnosis
Drs Natasha Ali, Kashif Khan, Haematology
Haematology Quiz
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Red cell mass (RCM) is the measurement of total 
volume of erythrocytes in the body. Its significance lies 
in the fact that Polycythemia Vera Study Group (PVSG) 
requires RCM to be measured for the diagnosis of 
polycythemia rubra vera (PRV) - a myeloproliferative 
disorder that is associated with absolute increase in red 
cells. The International Council for Standardization in 
Haematology (ICSH) has recommended that blood 
volume should be calculated in terms of body surface 
area.
RCM studies are based on dilutional analysis. The 
patient red cells are labeled with radioactive sodium 
chromate (Cr51) and injected intravenously. The 
dilution is measured after allowing sufficient time for 
Cr51 tagged red cells to become thoroughly mixed in 
circulation. From the dilution, the total blood volume of 
red cells can be calculated. Results are recorded as 
counts per seconds (cps) and background counting is 
measured by gamma counter. RCM is then calculated 
using body surface area. 
It is considered elevated if it is >25% above the mean 
expected value. False positive results can be observed in 
obese patients with PRV who has had significant 
recovery or during gastrointestinal blood loss. 
Red cell mass study helps to differentiate between 
absolute and apparent erythrocytosis. The former is the 
absolute raised red cell mass with normal plasma 
volume while the latter is spuriously high red cells 
counts secondary to reduced plasma volume. RCM is 
required for establishing the diagnosis of PRV. It is one 
of the chronic myeloproliferative disorders 
characterised by clonal proliferation of myeloid cells 
distinguished clinically from other myeloprpliferative 
disorders by the presence of increased red cell mass 
which results in increased red cell counts, elevated 
haemoglobin and increased haematocrit (packed cell 
volume). 
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Red Cell Mass Study
Dr Izza Hussain, Haematology
Diagnosis of PRV requires presence of two  major 
criteria or presence of any major with any two minor 
criteria. Additionally, presence of JAK-2 mutation 
(exon 14 or 12), Karyotyping abnormality other than 
t9:22, bone marrow biopsy showing hyper cellularity 
with prominent erythroid, granulocytes and 
megakaryocyte proliferation with characteristic 
absence of storage iron may be required for diagnosis. 
 Diagnostic Criteria for PRV
Major
! Increase red cell mass (25% above predictive value or PCV > 60 in males and 56 in females) 
!  Arterial oxygen saturation > 92%   with no elevation of serum erythropoietin (EPO) concentration 
!  Palpable Splenomegaly 
!  Acquired clonal genetic abnormality except BCR-ABL fusion
Minor   
9
!  Platelet count > 400 X 10 /L
9 9
!  WBC count > 10 X 10 / L  or 12 X 10 / L in smokers
!  Radiological splenomegaly
!  Endogenous erythroid colonies or low EPO 
What should a patient know before RCM studies?
1. It is a sufficiently long test requiring at least 2 hours for completion 
2. Ionic dyes are sometimes allergic, but this is a radio nucleotide scanning, it will not affect the patient's health 
(amount of chromium used in the study is <2 ìg/ml while toxic level is > 10 ìg/ml to inhibit glycolysis and > 5ìg/ml 
to inhibit glutathione reductase) 
3. Getting the blood back after tagging is part of the study and all the aseptic techniques are employed to ensure  safety 
4. During travelling, the patient will not be detected by metal detectors 
.5 
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Semen analysis is the most useful front-line test in the 
fertility work-up in males. It is essential that semen is 
collected according to pre-defined strict guidelines, so 
that a true picture of the fertility status may emerge. The 
test is simple, cheap, non-invasive and most informative.
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Azra Ali and Dr Shahid Pervez, Histopathology
Semen Analysis: An Invaluable Tool for 
Infertility Work-up
Sample Collection Guidelines
1. The sample should be collected after a minimum of 48 hours but no longer than seven days of sexual 
abstinence
2. Ideally the sample should be collected in the laboratory but if this is not possible it should be delivered to the 
laboratory within one hour of collection
3. The sample should be protected from extremes of temperature (less then 20°C - more then 40°C) during 
transportation
4. The sample should be obtained by masturbation into a clean, wide-mouth container (available at AKUH lab 
points)
5. The container must be adequately labeled with the subject's name and identification number
Like all biological specimens, semen samples may 
contain harmful infectious agents (for example HIV, 
hepatitis B) and should therefore be handled carefully. A 
normal semen sample liquefies within 60 minutes at 
room temperature, although in most cases this occurs 
within 15 minutes. After liquefaction the physical and 
microscopic examination is performed.
The semen contains spermatozoa and seminal plasma 
which is a semi-gelatinous fluid. Testis produce 
spermatozoa while the assessory glands namely the 
epididymis, prostate, seminal vesicles and bulbo-
urethral glands produce the seminal plasma.
The first part of ejaculate contains most of the 
spermatozoa suspended in prostatic and epididymal 
fluid while its last part has residual spermatozoa 
suspended in the vesicular fluid. 
The spermatozoa constitute only 1-5% of the total 
ejaculate. Spermatozoon is a unique cell which neither 
grows nor divides. It consists of a head, a mid piece and a 
tail. It is a highly specialised cell with considerable 
power of movement in order to complete its task of 
fertilisation of the oocyte.
Physical characteristics of semen like appearance, 
volume, viscosity are noted. Its pH is measured  and 
microscopic examination is also performed and  
reported.
8
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Nomenclature for Semen Variables
Azoospermia: Total absence of sperms in an ejaculate
Oligozoospermia: Reduced number of sperms in semen (less then 20 millions/ml)
Polyzoospermia: Increased number of sperms in semen (greater then 200 millions/ml)
Normozoospermia: Normal sperm counts
Aspermia: Total absence of an ejaculate
Haematospermia: The presence of blood in semen
Leukocytospermia: White Blood Cells in the semen
Normal Values for Human Ejaculate
Volume                       >2.0 ml
PH                              7.2-7.8
6concentration             20 x 10  spermatozoa/ml or more
motility                       >50%
morphology                >30% with normal morphology
WBC                          <1.0 millions/ml
Figure shows: 1-Normal, 2-Pyriform head, 3-Normal, 4-Amorphous head, 5-Bent head, 6-Amorphous head with thick 
mid-piece. (Acquired from WHO Lab. Manual - 1)
Microscopic 
Examination 
This is done to estimate 
total sperm count as well 
as percentage of motile 
sperms. Motility of the 
spermatozoa like rapid 
l inear  p rogress ion ,  
s l o w / n o n  l i n e a r  
progression and non 
progressive sperms. On 
morphology defects of 
head ( e.g. large, small 
tapered pyriform, round 
and amorphous heads), 
neck and mid-piece 
(namely bent head, thick 
mid-piece) and tail ( such 
as  short, multiple 
hairpins and bent tail) are 
noted.
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Foetal Anomaly Scan is done at Aga Khan University 
Hospital with dedicated appointment and time slot.
The objective of this scan is to examine the anatomy of 
foetus and assessing its normal growth along with 
evaluation of  placental position.  The structures 
examined include the brain, spine, heart, kidneys, lips, 
legs, feet, lungs, stomach, kidneys, bladders, umbilical 
cord and limbs. The liquor 
volume will also be assessed 
at the same time. Foetal 
anomalies are sometimes 
associated with abnormal 
liquor volume. A second 
appointment may be needed 
f o r  c o m p l e t i o n  o f  
examination if the foetus is 
in a position which makes 
scanning difficult or if the 
image is not very clear as in 
larger women. The best time 
to do this scan is around 20 
weeks of pregnancy because 
the baby's parts are not 
crowded and easily seen. 
The scan usually takes about 
20 minutes.
An anomaly scan will detect approximately 50% of 
significant abnormalities Their early detection enables 
appropriate and timely intervention and thus can 
decrease the tremendous psychological trauma and 
financial burden on the family and society.
The foetal anomaly scan is done to reassure a woman 
that her baby has no structural abnormalities. It aids to 
identify anomalies not compatible with life or those that 
a r e  a s s o c i a t e d  w i t h  
morbidity or disability. Most 
of the time, the scan will not 
review any abnormality. In 
fact, 98% of babies born are 
normal. If an abnormality is 
detected, rescanning may   
be carried out   by another 
doctor to confirm the 
diagnosis. In case of life 
threatening anomalies, for 
example anencephaly of 
foetus,  termination of 
pregnancy can be suggested. 
If the problem requires 
surgery soon after birth, for 
example gastroschisis, then 
preparations are made for 
surgery to be done after birth. If the abnormality is 
associated with chromosomal abnormality, then 
cordocentesis will be performed to determine the 
karyotype.
May 2009, Vol. 34, Issue 2
Dr Shaista Afzal; Muhammad Owais Khan, Radiology
Foetal Anomaly Scan 
Problem What the problem is Chance of being seen
Spina bifida Open spinal cord 90%
Anencephaly Absence of the top of the head 99%
Hydrocephalus Excess fluid within the brain 60%
Major congenital heart problems  25%
Diaphragmatic hernia A defect in the muscle which separates the chest 60%
and abdomen
Exomphalos/gastroschisis Defects of the abdominal wall 90%
Major kidney problems Missing or abnormal kidneys 85%
Major limb abnormalities Missing bones or very short limbs 90%
Cerebral palsy Spasticity Never seen
Autism  Never seen
Downs syndrome May be associated with heart and bowel problems About 40%
Figure: A foetal anomaly scans at 21 weeks.
Reference: Royal College of Obstetrics and Gynaecologists (2000)
The table below shows the major anomalies and their percentage chances of being detected.
10
Diagnosis of Helicobacter pylori Infection
H. pylorus is a helix-shaped gram-negative pathogen 
responsible for gastritis, peptic ulcer disease and gastric 
MALTomas in humans. It is also associated with the 
deve lopmen t  o f  ga s t r i c  adenoca rc inoma .  
Approximately 50percent of the world's population is 
affected by gastric H. pylori infection. Infection is more 
frequent in less developed countries like Pakistan, India 
and Bangladesh. Many invasive and non-invasive 
methods are available for the detection of H. pylori 
infection. If done properly all of these methods have a 
diagnostic accuracy of more than 95%. However, each 
test has its advantages and disadvantages. 
T i t e r s  o f  s e r u m  
immunoglobulin IgG and 
less frequently IgA to H. 
pylori is a quick and 
r e a d i l y  a v a i l a b l e  
modality for diagnosis. 
The sensitivity of this test 
is 76-84percent which is 
more sensitive than 
biopsy as in essence it 
s a m p l e s  t h e  e n t i r e  
stomach. The biopsy only 
samples a small region 
a n d  s i n c e  t h e  
inflammatory process 
may be patchy, it may be 
missed. However it does 
n o t  h e l p  i n  t h e  
determination of lesion or 
pathology and has no 
antimicrobial susceptibility. This test is available at 
AKUH laboratories.
IgG antibodies detection from saliva could be used 
reliably for screening dyspeptic patients in general 
practice, especially in children in whom venesection is 
NON INVASIVE METHODS
Serology (Blood Antibody Test)
Detection of Salivary H. Pylori Antibody
more difficult. However this test is not locally available 
up till now.
Stool antigen-testing allows non-invasive detection of 
H. pylori that is indicative of active infection. A positive 
result on the stool antigen test seven days after 
completion of therapy identifies patients in whom 
eradication of H. pylori was unsuccessful. The 
sensitivity of this test ranges from 86-94% and has a 
specificity of 92-97%. However it is not a quantitative 
test and like the serological test it does not help in the 
determination of lesion or pathology and has no 
antimicrobial susceptibility. This test is available at 
AKUH laboratories.
Urea breath test is an 
effect ive diagnost ic  
method for H. pylori. 
Results of these assays 
correlate with numbers  
of urease producing        
H. pylori organisms.  
This is the most valuable 
t e s t  f o r  a s s e s s i n g  
response to eradication 
therapy after 6 to 8   
 weeks. It hasa  sensitivity 
o f  9 0 - 9 5 %  a n d  a  
specificity of 94-100% 
But the drawback of this 
test is that it is expensive, 
involves administration 
of radioisotopes and is 
not quantitative. 
The gold standard method for detecting H. pylori 
infection is a biopsy taken during an endoscopy. This 
Stool Antigen Test
Urea Breath Test
INVASIVE METHODS
Endoscopy with Biopsy  
May 2009, Vol. 34, Issue 2
Sadia Omer, Microbiology
Figure 1: Helicobacter pylori H&E Stain
Courtesy Dr M Abrar Barakzai (Histopathology Section, AKUH)
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permits the inspection of pathology and allows the 
detection of ulcers, strictures and neoplasm. Biopsy 
specimens may be cultured for H. pylori but require 
expertise and resources. Another advantage is that 
antibiotic susceptibility testing could be performed. 
However it is an expensive and invasive procedure, and 
as compared to other diagnostic modalities is time 
consuming. 
Molecular Methods
PCR for the detection of H.pylori in tissue biopsy 
samples is available. Moreover polymerase chain 
reactions are available that could detect resistance genes 
and could therefore give an idea about the antimicrobial 
susceptibilities. However these tests are not widely 
available and are a research tool at this moment.
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HCV has infected nearly 170 million people worldwide. 
Out of this, 3/4 million are newly infected.  There are 
about 30percent cases of acute hepatitis and 80percent 
cases of chronic hepatitis that develop a risk of cirrhosis 
and hepatocellular carcinoma.  
The hepatitis C virus is a small 15 nm, enveloped, single 
stranded, positive sense RNA virus. It is a member of 
hepacivirus genus in the family flaviviridae. HCV 
genome is approximately 10,000 nucleotides which 
codes for 3,000 amino acids.
Due to different genetic variations several different 
strains of HCV are identified, called genotypes. With the 
advent of advanced molecular tests, HCV genome is 
classified into six main genotypes (1a-6a) and several 
subtypes (1a, 1b etc). The most common genotype in 
Asia including Pakistan is 3a.
Genotype information is important for patient 
management and prediction of treatment response. A 
genotype test requires a blood sample. RNA is extracted 
from serum and reverse transcribed (RT) to cDNA and 
amplified using polymerase chain reaction (PCR). The 
PCR product is denatured and hybridized to the 
nitrocellulose strip with HCV genotypes already bound 
to it. After hybridization of PCR product with the strip, 
conjugate is applied and substrate is added resulting in 
Afsheen M. Ibrahim, Molecular Pathology
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Figure 1: Model structure of HCV
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purple brown precipitate. A 
line is considered positive 
when a distinct brown spot 
appears on the strip as shown 
in figure 2.
The success rate of antiviral 
treatment (Interferon plus 
Ribavirin) ranges from 50-
90%. Genotype 1 has least 
response (50%) to therapy 
while genotype 2 and 3 show 
best response (nearly 90%). 
Genotype of a person remains 
the same throughout the 
treatment unless person is re-
in fec ted  wi th  ano the r  
genotype.  
At Aga Khan University 
H o s p i t a l ,  M o l e c u l a r  
Pathology Section of Clinical 
Laboratory, HCV in serum is 
tested by RNA extraction and 
amplification using Amplicor 
HCV assay and HCV positive 
samples are then genotyped 
using Linear Array HCV 
genotyping kit based on 
hybridization to genotype 
specific probes.
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Peripheral blood film shows characteristic large 
granules in neutrophil (left) and monocyte (right) 
seen in Chediak Higashi syndrome. 
Chediak Higashi syndrome is a fatal inherited 
autosomal recessive disorder characterised by a 
defect in formation of lysosomes in multiple cell 
lineages. Abnormally large granules in leucocytes 
and other granule containing cells is the hallmark 
charac te r i s t i c  and  d iagnos t i c  f ea tu re .  
Haematological abnormalities are most apparent in 
the granulocytic series although anaemia and 
thrombocytopenia also occur. Homozygotes for 
defective genes suffer from partial albinism, 
neurological abnormalities, and recurrent bacterial 
infections. 
Drs Natasha Ali, Kashif Khan, Haematology
Answer to Haematology Quiz
Figure 2: Banding pattern of genotypes on different strips.
Conjugate control line
(CONJ CTRL)
5'UTR amplification
control line
(AMPL CTRL 1)
19 genotype specific
lines
Core amplification
control line
(AMPL CTRL 2)
3 genotype specific lines
4 3a 3a N 2 1a
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